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Introduction
Frontal-subcortical syndrome (FSCS) is a broad-ranging disorder 
that primarily affects cognition, mood, and motor skills. This 
dysfunction is usually related to prevalent factors among the elderly 
population, such as strokes [1], small vessel lesions [2], and metabolic 
syndrome [3]. Its epidemiology is not precisely known. However, we do 
know that around 22% of the United States population older than 70 
years old has some kind of mild cognitive impairment with no criteria 
for specific dementias [4]. Although far from proper prevalence data, 
this statistic gives us a picture of the natural functional decline at least 
partially linked to frontal-subcortical impairment. This is a particularly 
serious concern, since the mortality for FSCS patients seems to be 
higher than the mortality of other cognitive impaired patients, such as 
those with Alzheimer’s disease, reaching 85% in a four-year follow-up 
[5].
Anatomy of Frontal-Subcortical Connections
The frontal lobe is a leading player for human superior functions. 
Restricted damage to certain parts of the frontal lobe, such as to 
prefrontal convexity, orbitofrontal, and medial frontal cortex, can 
cause specific and distinct syndromes. Nonetheless, the same pattern of 
syndromes can emerge from subcortical impairment, suggesting a well-
defined circuitry connecting these otherwise autonomous portions of 
brain [6]. There are at least five of these circuits anatomically described: 
motor, oculomotor, dorsolateral prefrontal, orbital frontal and anterior 
cingulate circuits. They all originate in prefrontal cortex and form a 
loop, passing through striatum, globus pallidus and substantia nigra, 
and finally through thalamus [7].
Motor and oculomotor circuits are required for coordination 
and initiation of muscle movement by the frontal cortex. The former 
originates in the supplementary motor area, premotor cortex, motor 
cortex, and somatosensory cortex. The later in the frontal eye field and 
posterior parietal cortex. The dorsolateral prefrontal, orbitofrontal, and 
anterior cingulate circuits work on cognitive tasks and motivational 
states. The dorsolateral prefrontal circuit operates in a wide range of 
functions, including planning, learning new information, activating 
remote memories, and adjusting behavioral sets. The orbitofrontal 
circuit has a crucial role for behavioral inhibition and emotional liability. 
Finally, the anterior cingulate circuit has a special role in motivation 
parameters [7]. It’s noteworthy that all the mentioned routes include the 
basal ganglia, which was once believed to be solely employed in motor 
coordination [8]. The actual knowledge of these anatomical features 
end up being of great value for a legitimate understanding of FSCS.
Frontal-Subcortical Syndrome and Metabolic Syndrome
One can define metabolic syndrome as the combinations of some 
or all of the following disturbances: obesity, high blood pressure, 
dyslipidemia, and insulin resistance; each of these is an independent 
risk factor for cardiovascular and endocrine disorders [9], and many, 
remarkably insulin resistance, are being discover to be associated 
also with neurological disease [10,11]. Roriz-Cruz et al. have shown, 
in 2007 [3], that metabolic syndrome predicts the development of 
FCSC in elderly subjects with an odds ratio of 5.9, being one of the 
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main such predictors; therefore, we feel that understanding each of this 
syndrome’s components’ relation with FSCS is fundamental to build a 
solid approach to this disease. 
Insulin resistance and frontal-subcortical syndrome
Insulin resistance is a bodily state in which higher levels of insulin 
are necessary to produce the same biological response that normal 
levels used to do [12]; it comprises both pre-diabetes and diabetes 
mellitus type 2. Although diabetes is known as a major cause of 
macro- and microvascular disease worldwide [13], we still understand 
little about how a hyperinsulinemic/hyperglycemic state causes vessel 
damage: whilst some research has implicated a role for excess glucose 
entry in endothelial mitochondria as a cause of oxidative stress and so 
endothelial damage [14], other groups have shown a role for advanced 
glycation end-products (AGEs) and eicosanoids [15-17]. It has been 
also demonstrated that diabetic patients can have superior cognitive 
function, including executive function, deficits [18,19], and elaborate 
neuroimaging studies in patients with this profile demonstrated that 
the deficit may be due to microvessel and axonal damage in the white 
matter connections between cortical and subcortical structures, as 
well as some cortical gray-matter areas [20,21]. Pugh and Lipsitz [2] 
have called, even before diffusion imaging had been made, this type of 
microvascular lesion against the white matter as “subcortical ischemic 
microangiopathy”, and shown that it is a major component in the FSCS; 
Zunker et al. [22] had previously shown, in a clinical study, that patients 
with cerebral microangiopathy have higher insulin plasma levels than 
control patients. Taking together this body of evidence, it is reasonable 
to state that insulin resistance is a main risk factor for FSCS. 
Obesity and FSCS
Obesity, commonly defined as a body mass index (BMI) equal 
or higher than 30, is an established cardiovascular risk factor; what 
is becoming increasingly discussed is its role as a risk factor for 
cognitive disorders: according to a very recent study by Lasselin et 
al. [23], obese individuals’ performance in tests with power to assess 
frontal executive function is lower than that of non-obese controls, 
and the authors attribute this difference to the persistent, low-grade 
inflammatory state promoted by excessive adipose tissue. A plethora of 
studies have demonstrated that obesity is indeed capable of promoting 
such an inflammation [24-26], and in two recent studies in human 
subjects using brain magnetic resonance imaging (MRI), brain small-
vessel disease [27,28]; moreover, obesity is straightforwardly linked to 
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the development of insulin resistant through the same inflammatory 
pathways [24,26], which per se is a major risk factor for FSCS (see 
section 3.1). 
Dyslipidemia and FSCS
There is controversial evidence that dyslipidemia (high blood LDL, 
high blood triglycerides, or low blood HDL) is linked to FSCS. Grotemeyer 
et al. have successfully demonstrated that, in humans, ischemic brain 
disease - comprising stroke, transient ischemic attack, and small-vessel 
disease – is associated with elevated plasma viscosity, which in turn is 
proportional to, amongst other factors, the concentration of plasma 
lipids [29]; however, leukoaraiosis, a surrogate measure of cerebral white 
matter small-vessel disease, is inversely associated with plasma lipid 
levels, which could indicate a protective role of these molecules against 
small-vessel disease [30]. In the study conducted by Roriz-Cruz et al. 
in 2007 on elderly people with metabolic syndrome and FSCS [3], total 
blood cholesterol was one of the few metabolic syndrome components 
that did not show a statistically significant association with the presence 
of FSCS, even though triglyceride levels did – this may suggest that the 
relationship between dyslipidemia and FSCS is more complex than it 
seems at first sight, and so that more studies must be made before we can 
draw any definitive conclusion about it. 
Hypertension and FSCS
The relationship between hypertension and FSCS is thought to be 
due to the role of high blood pressure in promoting small-vessel disease: 
according to a recent review by Østergaard et al. [31], hypertension 
causes small-vessel disease by leading to pericyte degeneration, 
swelling of endothelium and surrounding astrocytic vascular feet, and 
thickening of the basement membrane; enlarged perivascular space has 
also been reported as a consequence of hypertension [32]. Although 
there is plenty of evidence that hypertension is a major risk factor for 
small-vessel disease [33], there is also a striking paucity of data from the 
medical literature on whether anti-hypertensive treatment provides any 
benefit for this condition. 
Frontal Release Reflexes and FSCS
Frontal release reflexes (FRRs), sometimes also called “primitive 
reflexes”, are a central part of FSCS: while small-vessel disease probably 
accounts for the major pathophysiologic component of the syndrome, 
FRRs form the cornerstone of its diagnosis: For a patient to be 
considered as having FSCS, a commonly adopted diagnostic criterion 
is the presence of at least one FRR plus three or more of the following: 
cognitive impairment; late-onset depression; lower-limbs neuromotor 
dysfunction; and urgency urinary incontinence [3]. FRRs consist in 
early-life reflexes that are normally suppressed along the maturation 
of the frontal lobe and its connections, being thus absent in a normal 
individual after its infancy [34]. Since the disappearance of these 
reflexes relies on frontal lobe activity, damage to this brain area or its 
connections may result in the reappearance of one or more of these 
signs, as shown by studies evaluating the features of bilateral anterior 
cerebral artery infarction [35] and subcortical infarction of frontal-
subcortical pathways [36]. Age-induced hypometabolism of frontal 
cortex or putamen – structures involved in the corticostriatal motor 
circuit (see section 2) – as assessed by PET scanning was also associated 
with the presence of FRRs [37] confirms that such circuit function is 
necessary to suppress the primitive reflexes; as the pathophysiology 
of FSCS is determined by damage to these and other fibers, it makes 
sense that the syndrome should compromise the inhibition of primitive 
reflexes, leading to their release. 
The palmomental reflex, which consists in an involuntary contraction 
of chin and eyelids in response to painful thenar stimulations, is a high-
specific and low-sensitive test to detect for frontal lobe anatomical 
lesions [38]; however, still a significant share of health adult population 
can present this sign incidentally, and so usually more than just one 
positive FRR is necessary to indicate frontal damage without other 
signs [39]. There is currently not conclusive accuracy data for the other 
FRRs, but one can wonder that their sensitivity and specificity may 
behave as the ones of the palmomental reflex, since they are caused by 
the same kind of damage. Other common FRRs are the grasp reflex 
(hand and fingers contraction in response to palmar pressure stimulus), 
the sucking reflex (sucking movements with the lips when an object 
such as a spatula is inserted into the mouth), the snout reflex (plucking 
of the lips in response to nasal philtrum gentle pressure), glabellar 
reflex (bilateral eye blink in response to a tap in the glabella, which 
is the skin between the eyebrows), corneomandibular reflex (lateral 
movement of jaw in response to contralateral corneal stimulation), and 
the nuchocephalic reflex (holding of head position when the shoulders 
are vigorously turned to either side) [40]. The presence of any of such 
reflexes is enough to fulfill the FRR requirement for FSCS. 
Frontal-Subcortical Syndrome and Cognition
Although cognitive impairment may refer to decline in any of 
higher cognitive functions, in FSCS it is related tightly only to executive 
control malfunctioning, since this is the cognitive domain originated 
by the frontal-subcortical networks. Executive function can be defined 
broadly as being able of planning and performing complex, self-
interested activities [41], and may be measured with high sensitivity 
and low specificity by tests such as the Mini-Mental Status Examination 
(MMSE) [3]. The Montreal Cognitive Assessment (MoCA) has been 
suggested as equivalent to the MMSE regarding the sensitivity to 
cerebrovascular cognitive impairment [42], having the advantage of 
a greater specificity [43], but its use is not as widespread as MMSE’s. 
Approximately 20% of patients with FSCS present executive cognitive 
impairment [3]. 
As studies with Parkinson’s disease patients have told us, 
executive function impairment affects enormously quality of life [44]; 
nevertheless, and unfortunately, many researchers and doctors still 
regard it as “natural aging”, when in fact it is a major symptom of an 
underlying disease. This makes it probably underreported, and so 
the diagnosis of FSCS becomes harder to be made, since it is partially 
dependent on executive function decline. Other issue that one faces 
when suspecting FSCS based on executive control impairment is the 
ubiquitous presence of Alzheimer’s disease suspicion – having FSCS 
does not make a patient immune to having Alzheimer’s (nor vice-
versa), and the cognitive impairment caused by the latter can present 
in the same way as the one caused by the former: even a new subtype 
of Alzheimer’s disease, the “dysexecutive”, is now being discussed [45]. 
However, neuroimaging of the two conditions can be very different 
from each other, with a still predominant atrophy of temporal lobe in 
“dysexecutive Alzheimer’s” [46] and a white-matter lesion pattern at 
the frontal lobe in FSCS [2]. The dysexecutive symptoms in FSCS are 
thought to be due to dorsolateral prefrontal circuit lesions [7]. 
Frontal-Subcortical Syndrome and Depression
The second component of the FSCS diagnosis is late-onset 
depression [3], and that is explained by the fact that frontal cortex and 
caudate nucleus hypoactivity is associated to depression, which is well 
demonstrated in patient with Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease and epilepsy [7]. It is also known that strokes in 
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the dorsolateral prefrontal areas and basal ganglia might be implicated 
in depression pathogenesis [7,47]. In a Korean population, a study used 
suicide ideation scales and neuroimaging to show a reduced frontal-
subcortical white matter connectivity in patients with stronger suicide 
risk [48], and there is evidence that this may be caused by decreased 
activity or connectivity in the circuit involving the anterior cingulate 
cortex and the nucleus accumbens [7,49]. In patients with FSCS, this 
decrease in connectivity would be caused by small-vessel ischemic 
damage [2]. 
Approximately 16% of FSCS present late-onset depression, as 
diagnosed by the DSM-IV [3]. There is no data in the literature regarding 
depression estimates in FSCS as diagnosed by DSM-V criteria. 
Frontal-Subcortical Syndrome and “Neuromotor” 
Symptoms
Urinary urgency incontinence
Urinary urgency incontinence (UUI) is the involuntary loss of 
urine in urgency situations [50]. Although normally regarded as pelvic 
floor and detrusor muscle dysfunction, we now know that the anterior 
cingulate cortex plays a central role in the control of bladder filling and 
urine releasing [51], and, in patients with UUI, this brain region has an 
overt response to bladder filling interoceptive stimuli [52]. Therefore, 
it is no surprise that a significant share of patients with FSCS present 
UUI [3], since the pre-frontal cortex, with the help of the amygdala, 
functions as an inhibitor of anterior cingulate cortex activity [53], and 
patients with FSCS may have ischemic damage to the fibers responsible 
for this modulation [2]. 
Even though the evidence is robust for the association between 
ischemic white matter lesions leading to FSCS and UUI, we must 
acknowledge that a possible confounder in this relationship is that 
metabolic syndrome itself is strongly associated with the development 
of UUI, with an odds ratio of 4.8 [3], besides being associated with 
the development of FSCS; however, there is no reason to believe that 
metabolic syndrome accounts alone for the UUI cases in patients with 
FSC, being the answer to this question probably a composite of the 
metabolic factors, ischemic brain damage, and possibly other factors 
yet unknown. 
Lower-limb neuromotor dysfunction
In FSCS, lower-limb neuromotor dysfunction (LLND) usually 
comes up as a “fear of falling” [3], being thus a factor that worsens 
quality of life: in a 1994 cohort study [54], 19% of community-dwelling 
elders reported avoiding daily life activities because of fear of falling. 
Nevertheless, fear of falling is also a potentially reversible symptom in 
FSCS, with treatment strategies ranging from the use of video-games 
[55,56] to exercise programs [57], and so detection of this symptom 
should always be actively sought, especially because it is common for 
elderly patients to not report it spontaneously due to embarrassment 
and feeling that “it is not important”. 
Although usually thought as a “peripheral issue”, fear of falling 
is actually also related to damage to the superior frontal gyri and the 
supplementary motor area [58], that together form the frontal motor 
circuit (see section 2). We can also wonder if there is any influence 
from the anterior cingulate cortex, which is responsible, amongst 
other functions, for interoception, and this symptom, since Parkinson’s 
disease patients treated with deep-brain stimulation bilaterally of 
the subthalamic nuclei have had this fear tackled [59] when their 
parkinsonian symptoms were lowered. 
Final Comments
The frontal-subcortical syndrome is a long-debated, largely-ignored 
nosological entity, and we cannot help but to wonder if the explanation 
for this is that there is still much confusion about the concepts of 
“normal aging” and “healthy aging” or “successful aging”. “Normal 
aging” reflects a type of aging associated with cognitive and bodily 
functions decay that renders the elder a fragile, frail individual; while 
this may be “normal” in numerical ways, it is by no means the sole way 
or the best way of aging. “Successful aging”, at the other side, is achieved 
when the passage of time does not hamper independence for daily-life 
activities nor brings major debilitating diseases [60]; by definition, any 
FSCS symptom is not part of “successful aging”, and should not, in any 
way, be seen as such, even if it is “normal” or “usual”. 
There is also a lot of ongoing debate on the diagnostic criteria for 
FSCS, such as the use of apathy and anhedonia as a criterion instead of 
late-onset depression [2]. This is both bad and good: because we lack 
still precise criteria for its diagnosis, FSCS is probably underreported 
and underestimated as a cause of low quality of life; the bright side 
is that the presence of this debate reflects the growing interest in this 
disorder, and that will probably result in more understanding of the 
disease and so treatment options for the patients.
References
1. Kandiah N, Wiryasaputra L, Narasimhalu K, Karandikar A, Marmin M, et 
al. (2011) Frontal subcortical ischemia is crucial for post stroke cognitive 
impairment. J Neurol Sci 309: 92-95.
2. Pugh KG, Lipsitz LA (2002) The microvascular frontal-subcortical syndrome of 
aging. Neurobiol Aging 23: 421-431.
3. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, et al. (2007) Cognitive 
impairment and frontal-subcortical geriatric syndrome are associated with 
metabolic syndrome in a stroke-free population. Neurobiol Aging 28: 1723-
1736.
4. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, et al. (2008) 
Prevalence of cognitive impairment without dementia in the United States. Ann 
Intern Med 148: 427-434.
5. Pfitzenmeyer P, Mourey F, Manckoundia P, d’Athis P (2005) A 4 year follow-up 
of very old patients presenting with frontal-subcortical dysfunction compared 
with Alzheimer’s disease patients. Gerontology 51: 62-65. 
6. Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch 
Neurol 50: 873-880.
7. Tekin S, Cummings JL (2002) Frontal-subcortical neuronal circuits and clinical 
neuropsychiatry: an update. J Psychosom Res 53: 647-654.
8. Middleton FA, Strick PL (2000) Basal ganglia and cerebellar loops: Motor and 
cognitive circuits. Brain Res Brain Res Rev 31: 236-250.
9. Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: 
Definitions and controversies. BMC Med 9: 48.
10. Steculorum SM, Solas M, Brüning JC (2014) The paradox of neuronal insulin 
action and resistance in the development of aging-associated diseases. 
Alzheimers Dement 10: S3-11.
11. Mansur RB, Cha DS, Woldeyohannes HO, Soczynska JK, Zugman A, et al. 
(2014) Diabetes mellitus and disturbances in brain connectivity: A bidirectional 
relationship? Neuromolecular Med 16: 658-668.
12. Cefalu WT (2001) Insulin resistance: cellular and clinical concepts. Exp Biol 
Med (Maywood) 226: 13-26.
13. Szendroedi J, Saxena A, et al. (2016) Cohort profile: The German Diabetes 
Study (GDS). Cardiovasc Diabetol 15: 59.
14. Peiró C, Romacho T, Azcutia V (2016) Inflammation, glucose, and vascular 
cell damage: The role of the pentose phosphate pathway. Cardiovasc Diabetol 
15: 82.
15. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ 
Res 107: 1058-1070.
Citation: Starosta RT, Vidor MV, Roriz-Cruz M (2016) The Frontal-subcortical Syndrome. J Alzheimers Dis Parkinsonism 6: 247. doi: 10.4172/2161-
0460.1000247
Page 4 of 4
Volume 6   Issue 4 • 1000247
J Alzheimers Dis Parkinsonism
ISSN:2161-0460 JADP an open access journal 
16. Greifenhagen U, Frolov A, Blüher M, et al. (2016) Site-specific analysis of 
advanced glycation end products in plasma proteins of type 2 diabetes mellitus 
patients. Anal Bioanal Chem .
17. Hashimoto K, Kunikata H, Yasuda M, Ito A, Aizawa N, et al. (2016) The 
relationship between advanced glycation end products and ocular circulation in 
type 2 diabetes. J Diabetes Complications.
18. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, et al. (2001) 
Neuropsychological profiles of children with type 1 diabetes 6 years after 
disease onset. Diabetes Care 24: 1541-1546.
19. Brands AM, Kessels RP, Hoogma RP, Henselmans JM, van der Beek Boter 
JW, et al. (2006) Cognitive performance, psychological well-being and brain 
magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 
55: 1800-1806. 
20. Kodl CT, Franc DT, Rao JP, Anderson FS, Thomas W, et al. (2008) Diffusion 
tensor imaging identifies deficits in white matter microstructure in subjects with 
type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 
57: 3083-3089. 
21. Hsu JL Chen YL, Leu JG, Jaw FS, Lee CH, et al. (2012) Microstructural white 
matter abnormalities in type 2 diabetes mellitus: A diffusion tensor imaging 
study. Neuroimage 59: 1098-1105.
22. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nabavi DG, et al. (1996) 
Hyperinsulinism and cerebral microangiopathy. Stroke 27: 219-223.
23. Lasselin J, Magne E, Beau C, Aubert A, Dexpert S, et al. (2016) Low-grade 
inflammation is a major contributor of impaired attentional set shifting in obese 
subjects. Brain Behav Immun .
24. Hotamisligil GS (2008) Inflammation and endoplasmic reticulum stress in 
obesity and diabetes. Int J Obes (Lond) 32 Suppl 7: S52-54.
25. Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, et al. (2007) 
Coordinated regulation of nutrient and inflammatory responses by STAMP2 is 
essential for metabolic homeostasis. Cell 129: 537-548.
26. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, et al. (2002) A central 
role for JNK in obesity and insulin resistance. Nature 420: 333-336.
27. Dearborn JL, Schneider AL, Sharrett AR, Mosley TH, Bezerra DC, et al. (2015) 
Obesity, insulin resistance and incident small-vessel disease on magnetic 
resonance imaging: Atherosclerosis risk in communities study. Stroke 46: 3131-
3136. 
28. Kwon HM, Park JH, Park JH, Jeong HY, Lim JS, et al. (2016) Visceral fat is an 
independent predictor of cerebral microbleeds in neurologically healthy people. 
Cerebrovasc Dis 42: 90-96.
29. Grotemeyer KC, Kaiser R, Grotemeyer KH, Husstedt IW (2014) Association 
of elevated plasma viscosity with small vessel occlusion in ischemic cerebral 
disease. Thromb Res 133: 96-100.
30. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, et al. (2010) 
Hyperlipidemia and reduced white matter hyperintensity volume in patients with 
ischemic stroke. Stroke 41: 437-442. 
31. Østergaard L, Engedal TS, Moreton F, Hansen MB, Wardlaw JM, et al. (2016) 
Cerebral small vessel disease: Capillary pathways to stroke and cognitive 
decline. J Cereb Blood Flow Metab 36: 302-325.
32. Riba-Llena I, Nafría C, Mundet X, López-Rueda A, Fernández-Cortiñas I, et al. 
(2016) Assessment of enlarged perivascular spaces and their relation to target 
organ damage and mild cognitive impairment in patients with hypertension. Eur 
J Neurol 23: 1044-1050. 
33. Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical 
characteristics to therapeutic challenges. Lancet Neurol 9: 689-701.
34. Nicolson SE, Chabon B, Larsen KA, Kelly SE, Potter AW, et al. (2011) Primitive 
reflexes associated with delirium: A prospective trial. Psychosomatics 52: 507-512.
35. Kobayashi S, Maki T, Kunimoto M (2011) Clinical symptoms of bilateral anterior 
cerebral artery territory infarction. J Clin Neurosci 18: 218-222.
36. Corbett AJ, Bennett H, Kos S (1992) Frontal signs following subcortical 
infarction. Clin Exp Neurol 29: 161-171.
37. Matias-Guiu JA, Cabrera-Martín MN, Fernádez-Matarrubia M, Moreno-Ramos 
T, Valles-Salgado M, et al (2015) Topography of primitive reflexes in dementia: 
An F-18 fluorodeoxyglucose pósitron emission tomography study. Eur J Neurol 
22: 1201-1217. 
38. Ladino LD, Isaza S, Delgado J, Rascovsky S, Uribe C, et al. (2015) Diagnostic 
yield of the palmomental reflex in patients with suspected frontal lesion. J 
Neurol Sci 359: 156-160.
39. Isakov E, Sazbon L, Costeff H, Luz Y, Najenson T (1984) The diagnostic value 
of three common primitive reflexes. Eur Neurol 23: 17-21.
40. Schott JM, Rossor MN (2003) The grasp and other primitive reflexes. J Neurol 
Neurosurg Psychiatry 74: 558-560.
41. Abbatecola AM, Paolisso G, Lamponi M, Bandinelli S, Lauretani F, et al. (2004) 
Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 
52: 1713-1718.
42. Koski L (2013) Validity and applications of the Montreal cognitive assessment 
for the assessment of vascular cognitive impairment. Cerebrovasc Dis 36: 6-18.
43. Gil L, Ruiz de Sánchez C, Gil F, Romero SJ, Pretelt Burgos F (2015) Validation 
of the Montreal cognitive assessment (MoCA) in Spanish as a screening tool 
for mild cognitive impairment and mild dementia in patients over 65 years old in 
Bogotá, Colombia. Int J Geriatr Psychiatry 30: 655-662.
44. Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, et al. (2016) Cognitive 
decline and quality of life in incident Parkinson’s disease: The role of attention. 
Parkinsonism Relat Disord 27: 47-53.
45. Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, et al. (2016) The 
executive prominent/memory prominent spectrum in Alzheimer’s disease is 
highly heritable. Neurobiol Aging 41: 115-121.
46. Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, 
et al. (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: 
Clinical, neuroimaging and pathological features. Brain 138: 2732-2749. 
47. Mayberg HS (1994) Frontal lobe dysfunction in secondary depression. J 
Neuropsychiatry Clin Neurosci 6: 428-442.
48. Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, et al. (2016) 
Reduced frontal-subcortical white matter connectivity in association with 
suicidal ideation in major depressive disorder. Transl Psychiatry 6: e835. 
49. Craig AH, Cummings JL, Fairbanks L, Itti L, Miller BL, et al. (1996) Cerebral blood 
flow correlates of apathy in Alzheimer disease. Arch Neurol 53: 1116-1120.
50. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al. 
(2010) An International Urogynecological Association (IUGA)/International 
Continence Society (ICS) joint report on the terminology for female pelvic floor 
dysfunction. Int Urogynecol J 21: 5-26. 
51. Griffiths D, Derbyshire S, Stenger A, Resnick N (2005) Brain control of normal 
and overactive bladder. J Urol 174: 1862-1867.
52. Ketai LH, Komesu YM, Dodd AB, Rogers RG, Ling JM, et al. (2016) Urgency 
urinary incontinence and the interoceptive network: A functional magnetic 
resonance imaging study. Am J Obstet Gynecol.
53. Drevets WC (1999) Prefrontal cortical-amygdalar metabolism in major 
depression. Ann N Y Acad Sci 877: 614-637.
54. Proteau L, Charest I, Chaput S (1994) Differential roles with aging of visual 
and proprioceptive afferent information for fine motor control. J Gerontol 49: 
P100-107.
55. Morone G, Paolucci T, Luziatelli S, Iosa M, Piermattei C, et al. (2016) Wii Fit is 
effective in women with bone loss condition associated with balance disorders: 
A randomized controlled trial. Aging Clin Exp Res .
56. Levy F, Leboucher P, Rautureau G, Komano O, Millet B, et al. (2016) Fear 
of falling: Efficacy of virtual reality associated with serious games in elderly 
people. Neuropsychiatr Dis Treat 12: 877-881.
57. Kumar A, Delbaere K, Zijlstra GA, Carpenter H, Iliffe S, et al. (2016) Exercise 
for reducing fear of falling in older people living in the community: Cochrane 
systematic review and meta-analysis. Age Ageing 45: 345-352.
58. Tuerk C, Zhang H, Sachdev P, Lord SR, Brodaty H, et al (2016) Regional gray 
matter volumes are related to concern about falling in older people: A voxel-
based morphometric study. J Gerontol A Biol Sci Med Sci 71: 138-144. 
59. Nilsson MH, Fransson PA, Jarnlo GB, Magnusson M, Rehncrona S (2009) The 
effects of high frequency subthalamic stimulation on balance performance and 
fear of falling in patients with Parkinson’s disease. J Neuroeng Rehabil 6: 13.
60. Rowe JW, Kahn RL (1987) Human aging: Usual and successful. Science 237: 
143-149.
